Shares of Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) were down 19.6% on Saturday . The stock traded as low as C$0.18 and last traded at C$0.19. Approximately 802,183 shares changed hands during mid-day trading, an increase of 866% from the average daily volume of 83,002 shares. The stock had previously closed at C$0.23.
Nanalysis Scientific Price Performance
The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42. The business has a 50 day moving average price of C$0.24 and a 200-day moving average price of C$0.27. The company has a market capitalization of C$20.95 million, a price-to-earnings ratio of -1.68 and a beta of -0.75.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
See Also
- Five stocks we like better than Nanalysis Scientific
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Auto Tariffs Are Coming Down: 3 Stocks to Benefit Soon
- The 3 Best Blue-Chip Stocks to Buy Now
- Tencent Music Stock Outshines Spotify as China’s Music Giant
- Energy and Oil Stocks Explained
- DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
